EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Metabotropic Glutamate Receptor Involvement in Models of Acute and Persistent Pain: Prospects for the Development of Novel Analgesics

M A Varney, R W Gereau

Current Drug Target -CNS & Neurological Disorders · 2002

DOI: 10.2174/1568007023339300 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Drug Target -CNS & Neurological Disorders, 2002. Verfasst von M A Varney und 1 weiteren Autor:innen. Beteiligte Einrichtung: Merck Research Labs-San Diego, 3535 General Atomics Court, San Diego, CA 92121, USA. mark_varney@merck.com. Hauptthemen laut MEDLINE: Disease Models, Animal. Die Arbeit wurde bisher 99-mal zitiert (Crossref). Gefördert von: NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The excitatory amino acid glutamate plays a major role in nociceptive processing. Ionotropic and metabotropic glutamate receptors are expressed in relevant areas of the brain, spinal cord and periphery that are involved in pain sensation and transmission. Activation of mGlu receptors along the pain neuraxis can result in either pronociceptive or antinociceptive behaviors depending on the subtype of mGluR and its location. The data published to date most strongly support the idea that mGlu1 antagonists might act as broad-spectrum analgesics. Several studies pointing to a functional upregulation of mGlu2/3 in chronic pain models suggest that agonists of these receptors might also be effective analgesics in certain conditions, most notably inflammation-induced hyperalgesia and allodynia. The expression of mGluRs throughout the pain neuraxis and the differing roles of the mGluRs in each of these regions makes it difficult to predict the efficacy of mGluR ligands based on in vitro or local administration studies. Potent, systemically active compounds that show mGluR subtype selectivity will be critical to undertake more detailed analyses in animal models of pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease Models, AnimalAcute DiseaseAnalgesicsAnimalsChronic DiseaseDrug Delivery SystemsHumansPainReceptors, Metabotropic GlutamateTechnology, Pharmaceutical

Substanzen

AnalgesicsReceptors, Metabotropic Glutamate

Autor:innen und Institutionen

  • Merck Research Labs-San Diego, 3535 General Atomics Court, San Diego, CA 92121, USA. mark_varney@merck.com

Förderung

  • NIMH NIH HHS

Zitieren

APA

Varney, M. A., & Gereau, R. W. (2002). Metabotropic Glutamate Receptor Involvement in Models of Acute and Persistent Pain: Prospects for the Development of Novel Analgesics. Current Drug Target -CNS & Neurological Disorders. https://doi.org/10.2174/1568007023339300

Vancouver

Varney MA, Gereau RW. Metabotropic Glutamate Receptor Involvement in Models of Acute and Persistent Pain: Prospects for the Development of Novel Analgesics. Current Drug Target -CNS & Neurological Disorders. 2002. doi:10.2174/1568007023339300

BibTeX
@article{Varney2002,
  author = {Varney, M A and Gereau, R W},
  title = {Metabotropic Glutamate Receptor Involvement in Models of Acute and Persistent Pain: Prospects for the Development of Novel Analgesics},
  journal = {Current Drug Target -CNS & Neurological Disorders},
  year = {2002},
  doi = {10.2174/1568007023339300}
}
Kostenlos starten →